Resistance to Targeted Therapies in Breast Cancer
(Bog, Paperback / softback, Engelsk)
Beskrivelse
We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).
Læsernes anmeldelser (0)
Alle detaljer
| Forlag | Springer International Publishing AG |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgave | Softcover Reprint of the Original 1st 2017 ed. |
| Udgivelsesdato | 23-06-2018 |
| Første udgivelsesår | 2018 |
| Serie | Resistance to Targeted Anti-Cancer Therapeutics |
| Illustrationer | 12 Illustrations, black and white |
| Fagredaktør | Jenifer R. Prosperi |
| Originalsprog | Switzerland |
| Sideantal | 184 |
| Indbinding | Paperback / softback |
| Forlag | Springer International Publishing AG |
| Sideoplysninger | 184 pages, 12 Illustrations, black and white |
| Mål | 235 x 155 |
| ISBN-13 / EAN-13 | 9783319888910 |